Anti-IL13RA2 (clone hu08)-Mc- ADC

  • 1.00 Dollar US$
  • Published date: December 18, 2017
    • Shirley, New York, United States

https://www.creative-biolabs.com/adc/target-il13ra2-57.htm This ADC product is comprised of an anti- IL13RA2 monoclonal antibody (clone hu08) conjugated via a Mc linker to a drug. Noncleavable linkers, is considered noncleavable-meaning linker cleavage, and payload release does not depend on the differential properties between the plasma and some cytoplasmic compartments. Instead, the release of the cytotoxic drug is postulated to occur after internalization of the ADC via antigen-mediated endocytosis and delivery to lysosomal compartment, where the antibody is degraded to the level of amino acids through intracellular proteolytic degradation.

Result 0 votes
Bella
1 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Anti-IL13RA2 (clone hu08)-MalPeg ADC

    Anti-IL13RA2 (clone hu08)-MalPeg ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-il13ra2-57.htm This ADC product is comprised of an anti- IL13RA2 monoclonal antibody (clone hu08) conjugated via an MalPeg linker to a drug. Noncleavable linkers, is considered noncleavable-meaning linker c...

  • Anti-HAVCR1 (clone CR-014)-VC-MMAE ADC

    Anti-HAVCR1 (clone CR-014)-VC-MMAE ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-havcr1-53.htm This ADC product is comprised of an anti-HAVCR1 monoclonal antibody (clone CR-014) conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivere...

  • Anti-GUCY2C (clone 5F9)-VC-MMAE ADC

    Anti-GUCY2C (clone 5F9)-VC-MMAE ADC

    Drug Development Shirley (New York) December 18, 2017 1.00 Dollar US$

    https://www.creative-biolabs.com/adc/target-gucy2c-52.htm This ADC product is comprised of an anti-GUCY2C monoclonal antibody (clone 5F9) conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered i...